David B. Chou

3.2k citations

11 papers · 1.6k indexed · 1 hit paper · h-index 9

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Parasitology top 5%
- Toxoplasma gondii Research Studies

Papers in

Parasitology 2
Genetics 2
- Chronic Lymphocytic Leukemia Research 1

Co-authors: Yasmine Belkaid Michael E. Grigg Neel Joshi Ilia Gelfat Pichet Praveschotinunt Anna Duraj‐Thatte Liliane Martins dos Santos Elizabeth A. Wohlfert
Journals: Immunity (2 papers)Nature Communications (2 papers)Clinical Cancer Research (1 paper)PLoS Pathogens (1 paper)Modern Pathology (1 paper)
Partner nations: United States Germany Portugal

In The Last Decade

David B. Chou

11 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut 2019 · 327 citations

Peers

Countries citing papers authored by David B. Chou

Since Specialization

Citations

This map shows the geographic impact of David B. Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Chou more than expected).

Fields of papers citing papers by David B. Chou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Chou. The network helps show where David B. Chou may publish in the future.

Co-authors

The 25 scholars most cited alongside David B. Chou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Chou Line = papers co-authored together David B. Chou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work
1	Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors Nature Communications ·David B. Chou, M. Lavanya., Hirofumi Otani, Christos Kyprianou, Lucy R. O’Sullivan, Rhiannon David, Suzanne J. Randle, Urszula M. Polanska, Jon Travers, Jelena Urosevic, John N. Hutchinson, Jianwei Che, ジュンイチノガミ, Robert P. Hasserjian, Rachelle Prantil‐Baun, Donald E. Ingber	2022	4
2	Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology Cellular and Molecular Gastroenterology and Hepatology ·Alexandra Sontheimer-Phelps, David B. Chou, Alessio Tovaglieri, Thomas C. Ferrante, HeBinhui XieGuohui, Cicely W. Fadel, Viktoras Frismantas, Joël Anani, Sasan Jalili‐Firoozinezhad, Magdalena Kasendra, Eric Stas, James C. Weaver, Camilla A. Richmond, Oren Levy, Rachelle Prantil‐Baun, David T. Breault, Donald E. Ingber	2019	183
3	Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites Microbiome ·Alessio Tovaglieri, Alexandra Sontheimer-Phelps, Annelies Geirnaert, Rachelle Prantil‐Baun, Diogo M. Camacho, David B. Chou, Sasan Jalili‐Firoozinezhad, Tomás de Wouters, Magdalena Kasendra, Michael Super, Mark Cartwright, Camilla A. Richmond, David T. Breault, Christophe Lacroix, Donald E. Ingber	2019	115
4	Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut Nature Communications ·Pichet Praveschotinunt, Anna Duraj‐Thatte, Ilia Gelfat, Xiaozhuo Sun, David B. Chou, Neel Joshi Hit paper breakdown →	2019	327
5	EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations Modern Pathology ·Elizabeth L. Courville, Sophia Yohe, David B. Chou, Valentina Nardi, Aleksandr Lazaryan, Beenu Thakral, Andrew C. Nelson, Judith A. Ferry, Aliyah R. Sohani	2016	32
6	Case 1-2016 New England Journal of Medicine ·Nancy Berliner, Trappetti Claudia, David B. Chou	2016	6
7	miR-182 and miR-10a Are Key Regulators of Treg Specialisation and Stability during Schistosome and Leishmania-associated Inflammation PLoS Pathogens ·Samir N. P. Kelada, Praveen Sethupathy, Isobel Okoye, Wolfgang W. May, Stephanie Czieso, Sandra White, David B. Chou, Craig Martens, Stacy Ricklefs, Kimmo Virtaneva, Dan E. Sturdevant, Stephen F. Porcella, Yasmine Belkaid, Thomas A. Wynn, Mark S. Wilson	2013	91
8	Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection Journal of Leukocyte Biology ·David B. Chou, Brian J. Sworder, Nicolas Bouladoux, Cindy N. Roy, J. H. Nantel, Michael E. Grigg, Pamela Gehron Robey, Yasmine Belkaid	2012	62
9	Essential Role for Retinoic Acid in the Promotion of CD4+ T Cell Effector Responses via Retinoic Acid Receptor Alpha Immunity ·Jason A. Hall, Jennifer L. Cannons, John R. Grainger, Liliane Martins dos Santos, Timothy W. Hand, Shruti Naik, Elizabeth A. Wohlfert, David B. Chou, Guillaume Oldenhove, Mary Ann Robinson, Michael E. Grigg, Robin J. Kastenmayer, Pamela L. Schwartzberg, Yasmine Belkaid	2011	292
10	Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma Clinical Cancer Research ·Giang Huong Nguyen, Aaron J. Schetter, David B. Chou, Elise D. Bowman, Ronghua Zhao, Jason E. Hawkes, Ewy A. Mathé, Kensuke Kumamoto, Yiqiang Zhao, Anuradha Budhu, Nobutoshi Hagiwara, Xin Wei Wang, Masao Miyashita, Alan G. Casson, Curtis C. Harris	2010	58
11	Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection Immunity ·Guillaume Oldenhove, Nicolas Bouladoux, Elizabeth A. Wohlfert, Jason A. Hall, David B. Chou, Liliane Martins dos Santos, Shaun O’Brien, Rebecca B. Blank, Erika Lamb, S. Natarajan, Robin J. Kastenmayer, Christopher A. Hunter, Michael E. Grigg, Yasmine Belkaid	2009	464

About David B. Chou

David B. Chou is a scholar working on Parasitology, Genetics, Hematology, Infectious Diseases and Immunology, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (2 papers), Immune Cell Function and Interaction (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Drug Transport and Resistance Mechanisms (1 paper), Probiotics and Fermented Foods (1 paper) and Parvovirus B19 Infection Studies (1 paper). The work is most often cited by research in Immunology (671 citations), Parasitology (114 citations), Biotechnology (79 citations), Molecular Biology (576 citations) and Oncology (225 citations). David B. Chou has collaborated with scholars based in United States, Germany and Portugal. Frequent co-authors include Yasmine Belkaid, Michael E. Grigg, Neel Joshi, Ilia Gelfat, Pichet Praveschotinunt, Anna Duraj‐Thatte, Liliane Martins dos Santos, Elizabeth A. Wohlfert, Robin J. Kastenmayer and Guillaume Oldenhove. Their work appears in journals such as Immunity, Nature Communications, Clinical Cancer Research, PLoS Pathogens and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact